作者:
Julia,Krombach [1]
;
Roman,Hennel [1]
;
Nikko,Brix [1]
;
Michael,Orth [1]
;
Ulrike,Schoetz [2]
;
Anne,Ernst [3]
;
Jessica,Schuster [1]
;
Gabriele,Zuchtriegel [4]
;
Christoph A,Reichel [1]
;
Susanne,Bierschenk [5]
;
Markus,Sperandio [1]
;
Thomas,Vogl [6]
;
Steffen,Unkel [7]
;
Claus,Belka [8]
;
Kirsten,Lauber [6]
作者单位:
Department of Radiation Oncology, University Hospital, Munich, Germany.
[1]
German Cancer Consortium (DKTK), Munich, Germany.
[2]
German Cancer Research Center (DKFZ), Heidelberg, Germany.
[3]
Department of Radiotherapy and Radiooncology, Philipps-University Marburg, University Hospital Gießen and Marburg, Marburg, Germany.
[4]
Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California, USA.
[5]
Department of Otorhinolaryngology, University Hospital, Munich, Germany.
[6]
Walter Brendel Centre of Experimental Medicine, University Hospital, Munich, Germany.
[7]
Translational research in haematology/oncology, Institute of Experimental Infectious Diseases and Cancer Research, Division of the University Children's Hospital of Zurich, Zurich, Switzerland.
[8]
Institute of Immunology, University of Münster, Münster, Germany.
[9]
Department of Medical Statistics, University Medical Center, Goettingen, Germany.
[10]
Clinical Cooperation Group 'Personalized Radiotherapy in Head and Neck Cancer' Helmholtz Center Munich, German Research Center for Environmental Health GmbH, Neuherberg, Germany.
[11]
DOI
10.1080/2162402X.2018.1523097
PMID
30546963
发布时间
2021-01-12